NCT07027332View on ClinicalTrials.gov

Liver Stiffness And Steatosis Assessment In Women With Polycystic Ovary Syndrome Using Fibroscan

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

May 29, 2024

Primary Completion Date

January 30, 2025

Study Completion Date

March 8, 2025

Conditions
Polycystic Ovary SyndromeNon-Alcoholic Fatty Liver Disease
Interventions
DIAGNOSTIC_TEST

FibroScan® (Echosens, Paris, France)

A non-invasive liver elastography device used for clinical assessment. Liver steatosis and stiffness are measured in participants using the FibroScan device.

Trial Locations (1)

34035

Bezmialem Vakıf University, Istanbul

All Listed Sponsors
lead

Bezmialem Vakif University

OTHER

NCT07027332 - Liver Stiffness And Steatosis Assessment In Women With Polycystic Ovary Syndrome Using Fibroscan | Biotech Hunter | Biotech Hunter